SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-008514
Filing Date
2023-03-16
Accepted
2023-03-16 16:51:57
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a_-_notice_and_acc.htm DEFA14A 35684
2 GRAPHIC img39799937_0.jpg GRAPHIC 114533
3 GRAPHIC img39799937_1.jpg GRAPHIC 111441
  Complete submission text file 0000950170-23-008514.txt   348259
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 23739537
SIC: 2834 Pharmaceutical Preparations